So-Hyun Yoon

Title: So-Hyun Yoon: Innovator in Pharmaceutical Chemistry

Introduction

So-Hyun Yoon is a notable inventor based in Yongin-si, South Korea. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on crystalline forms of compounds. Her research focuses on developing stable pharmaceutical compositions that can effectively treat various diseases.

Latest Patents

So-Hyun Yoon holds a patent for a novel crystalline form of 5-chloro-N-({(5S)-2-oxo-3-[4-(5,6-dihydro-4H-[1,2,4]triazin-1-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide methanesulfonate. This invention relates to a pharmaceutical composition that exhibits excellent stability even in high-temperature and humidity environments. The compound is particularly useful in preventing or treating diseases such as thrombosis, myocardial infarction, atherosclerosis, inflammation, stroke, angina pectoris, restenosis after angioplasty, and thromboembolism.

Career Highlights

Throughout her career, So-Hyun Yoon has worked with reputable companies in the pharmaceutical industry. She has been associated with The Green Cross Corporation and Legochem Biosciences, Inc., where she has contributed her expertise in drug development and formulation.

Collaborations

So-Hyun Yoon has collaborated with several professionals in her field, including Soongyu Choi and Jungsub Choi. These collaborations have further enhanced her research and development efforts in pharmaceutical innovations.

Conclusion

So-Hyun Yoon is a distinguished inventor whose work in pharmaceutical chemistry has the potential to significantly impact the treatment of various medical conditions. Her innovative approaches and stable formulations are paving the way for advancements in the pharmaceutical industry.